It is well established that MALAT1 has oncogenic functions in various cancer types [105], and depletion of MALAT1 leads to TP53 upregulation, possibly due to double-stranded DNA damage [106], indicating that TP53 might be a target of MALAT1 as well. Here, TP53 is linked to cancer.